Search Results - S. Veersema

Challenges in Removing the Essure® Device by Daniëlle M. van Gastel, Liselotte W. Maassen, Carolien A. M. Koks, Sebastiaan Veersema, Marlies Y. Bongers

Connect to this object online.

Intracavitary deposits on Essure® hysteroscopic sterilization devices: A case report by L.W. Maassen, D.M. van Gastel, E.G.W.M. Lentjes, M.Y. Bongers, S. Veersema

Connect to this object online.

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?AJOG MFM at a Glance by Patty A.H.H. van der Heijden, MD, Peggy M.A.J. Geomini, MD, PhD, Iris Ketel, MD, PhD, Sebastiaan Veersema, MD, PhD, Marlies Y. Bongers, MD, PhD

Connect to this object online.

Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study by Duvekot Johannes J, Sikkema Marko J, Bilardo Katia M, Oudijk Martijn A, Woiski Mallory, Willekes Christine, Bloemenkamp Kitty WM, Bossuyt Patrick M, Porath Martina, van Wassenaer Aleid, de Miranda Esteriek, Pajkrt Eva, Kleinrouweler C, van der Ven Jeanine A, van Os Melanie A, Veersema Diederik, Laudy Jacqueline, Kuiper Petra, de Groot Christianne JM, Mol Ben Willem J, Haak Monique C

Connect to this object online.

The randomised uterine septum transsection trial (TRUST): design and protocol by J. F. W. Rikken, C. R. Kowalik, M. H. Emanuel, M. Y. Bongers, T. Spinder, J. H. de Kruif, K. W. M. Bloemenkamp, F. W. Jansen, S. Veersema, A. G. M. G. J. Mulders, A. L. Thurkow, K. Hald, A. Mohazzab, Y. Khalaf, T. J. Clark, M. Farrugia, H. A. van Vliet, M. S. Stephenson, F. van der Veen, M. van Wely, B. W. J. Mol, M. Goddijn

Connect to this object online.